| Style | Citing Format | 
|---|---|
| MLA | Haghiaminjan H, Kouhestani M, Hosseini A. "The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies." Metabolic Brain Disease, vol. 40, no. 1, 2025, pp. -. | 
| APA | Haghiaminjan H, Kouhestani M, Hosseini A (2025). The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies. Metabolic Brain Disease, 40(1), -. | 
| Chicago | Haghiaminjan H, Kouhestani M, Hosseini A. "The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies." Metabolic Brain Disease 40, no. 1 (2025): -. | 
| Harvard | Haghiaminjan H, Kouhestani M, Hosseini A (2025) 'The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies', Metabolic Brain Disease, 40(1), pp. -. | 
| Vancouver | Haghiaminjan H, Kouhestani M, Hosseini A. The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies. Metabolic Brain Disease. 2025;40(1):-. | 
| BibTex | @article{ author = {Haghiaminjan H and Kouhestani M and Hosseini A}, title = {The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies}, journal = {Metabolic Brain Disease}, volume = {40}, number = {1}, pages = {-}, year = {2025} } | 
| RIS | TY  - JOUR AU - Haghiaminjan H AU - Kouhestani M AU - Hosseini A TI - The Neuroprotective Effects of Progesterone Against Peripheral Neuropathy: A Systematic Review of Non-Clinical Studies JO - Metabolic Brain Disease VL - 40 IS - 1 SP - EP - PY - 2025 ER - |